tiprankstipranks

Aaron I. Davis Insider Profile

11 Followers
Aaron I. Davis, Director at Mirati Therapeutics, holds 0.00 shares in Rain Oncology (Ticker: RAIN), holds 0.00 shares in Mirati Therapeutics (Ticker: MRTX), holds 14.39M shares in Tango Therapeutics (Ticker: TNGX).
tipranks
Aaron I. Davis

Aaron I. Davis
Mirati Therapeutics (MRTX)
Director

Ranked #87,625 out of 98,624 Corporate Insiders

Profitable Transactions

38%
6 out of 16 Profitable Transactions

Average Return

-17.80%
Average return per transaction
Time Frame
1 Year
Compare to
No Benchmark

Insider Holdings

$99B
99.87%
0.11%
0.03%
A breakdown of Aaron I. Davis's holdings

Insider Roles

Odonate Inc
(ODTCD)
Director, Ten Percent Owner
Tango Therapeutics
(TNGX)
Director
iTeos Therapeutics
(ITOS)
Director
Roles that Aaron I. Davis holds in companies

Most Profitable Insider Trade

Stock:
Odonate Inc
(ODTCD)
Rating:Informative Buy
Date:Dec 27, 2018 - Dec 27, 2019
Return:+150.50%
The most profitable trade made by Aaron I. Davis

Aaron I. Davis's Trading History

Company Name
Last Transaction Date
Insider Position
Last Transaction
Last Transaction Amount
Holding Value
MRTX
Mirati Therapeutics
Jan 23, 2024
Uninformative Sell
$0.00
Odonate Inc
Nov 19, 2021
Director, Ten Percent Owner
Informative Sell
2.49M
$98.78B
iTeos Therapeutics
May 11, 2022
Director
Informative Sell
13.94M
$25.37M
RAIN
Rain Oncology
Jan 26, 2024
Uninformative Sell
$0.00
Tango Therapeutics
Jun 08, 2023
Director
Uninformative Buy
$104.73M
List of latest transactions for each holding click on a transaction to see Aaron I. Davis's performance on stock

Aaron I. Davis insider profile FAQ

What is the percentage of profitable transactions made by Aaron I. Davis?
The percentage of profitable transactions made by Aaron I. Davis is 38%.
    What is the average return per transaction made by Aaron I. Davis?
    The average return per transaction made by Aaron I. Davis is -17.80%.
      What stocks does Aaron I. Davis hold?
      Aaron I. Davis holds: MRTX, ODTCD, ITOS, RAIN, TNGX stocks.
        What was Aaron I. Davis’s latest transaction?
        Aaron I. Davis latest transaction was an Uninformative Sell of ―.
          What was Aaron I. Davis's most profitable transaction?
          Aaron I. Davis’s most profitable transaction was an Informative Buy of ODTCD stock on December 27, 2018. The return on the trade was 150.50%.
            What is Aaron I. Davis's role in Mirati Therapeutics?
            Aaron I. Davis's role in Mirati Therapeutics is Director.
              How can I follow the stock ratings of top corporate insiders?
              Head over to our Expert Center to see a list of the Top 100 corporate insiders and follow the corporate insiders of your choice. Visit their profiles for more details about their stock transactions and see how they perform on a stock-by-stock basis.